Farther Finance Advisors, LLC Amneal Pharmaceuticals, Inc. Transaction History
Farther Finance Advisors, LLC
- $2.77 Trillion
- Q4 2024
A detailed history of Farther Finance Advisors, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 12 shares of AMRX stock, worth $99. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 10
20.0%
Holding current value
$99
Previous $83,000
14.46%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AMRX
# of Institutions
204Shares Held
124MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$123 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$102 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$93.4 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$88.8 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$74.4 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.25B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...